| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Zhu (Tao)
|
17.984m | 7.82% | — | Dec 31 2025 |
| 2 |
Yu (Xuefeng)
|
17.974m | 7.81% | — | Dec 31 2025 |
| 3 |
Qiu (Dongxu)
|
17.114m | 7.44% | — | Dec 31 2025 |
| 4 |
Mao (Helen Huihua)
|
9.207m | 4.00% | — | Dec 31 2025 |
| 5 |
Shanghai Qianxiyi Enterprise Management Partnership (LP)
|
3.475m | 1.51% | — | Dec 31 2025 |
|
1
Zhu (Tao)
|
7.82%
17.984m
|
|
2
Yu (Xuefeng)
|
7.81%
17.974m
|
|
3
Qiu (Dongxu)
|
7.44%
17.114m
|
|
4
Mao (Helen Huihua)
|
4.00%
9.207m
|
|
5
Shanghai Qianxiyi Enterprise Management Partnership (LP)
|
1.51%
3.475m
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. | |
| The 5 largest shareholders together hold 28.59% of Cansino Biologics Inc-h, with Zhu (Tao) the biggest at 7.82%, followed by Yu (Xuefeng) (7.81%) and Qiu (Dongxu) (7.44%). |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


